Arcus Biosciences, Inc.
S&P 600
$24.59
-5.97%
Delayed · cached 15 min
Price Chart
Price50-day avg200-day avg
How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.
✓Strengths
- Low debt: debt-to-equity of 0.21.
- Current assets comfortably cover current liabilities (current ratio 4.36).
!Watch-points
- Thin interest cover: operating profit covers interest only about -42.9 times.
- Return on equity is on the lower side at -76.1%.
- Return on capital employed is on the lower side at -55.7%.
- The company reported a net loss in the latest period.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Piotroski F-ScoreWeak
0 / 7
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 7 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Market Cap$3.09B
Current Price$ 24.59
High / Low$ 31.74 / 11.30
Stock P/E-7.47
Book Value$ 3.68
Dividend Yield0%
ROCE-55.70%
ROE-76.08%
Debt to Equity0.21
Current Ratio4.36
P/B Ratio6.7296114
EPS$ -3.29
Debt$99.00M
PAT Margin-1069.70%
Cash PAT$-343.00M
ICR-42.89